Description: Bod Australia Limited operates as a cannabidiol and medical cannabis healthcare company in Australia, the United Kingdom, the European Union, and the United States. The company operates through three segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.
Home Page: bodaustralia.com
BOD Technical Analysis
377 New South Head Road
Double Bay,
NSW
2028
Australia
Phone:
61 2 9199 5018
Officers
| Name | Title |
|---|---|
| Ms. Joanne Patterson | CEO, Exec. Director & Member of Medical Advisory Board |
| Mr. Adrian Sturrock | Chief Financial Officer |
| Mr. Craig Weller | COO & Member of Medical Advisory Board |
| Dr. Adele Hosseini | Chief Scientific Officer & Member of Medical Advisory Board |
| Mr. Alan Dworkin ACIS, BBus, CA | Advisor |
| Mr. Stephen Kelly | Company Sec. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.067 |
| Price-to-Sales TTM: | 4.5163 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |